Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study
Authors:Hoffman Lindsey M (United States, Americas)Fouladi Maryam (United States, Americas)Olson James (United States, Americas)Daryani Vinay M (United States, Americas)Stewart Clinton F (United States, Americas)
+ 11 more
Wetmore Cynthia (United States, Americas)Kocak Mehmet (Turkey, Asia)Onar Thomas Arzu (United States, Americas)Wagner Lars (United States, Americas)Gururangan Sridharan (United States, Americas)Packer Roger J (United States, Americas)Blaney Susan M (United States, Americas)Gajjar Amar (United States, Americas)Kun Larry E (United States, Americas)Boyett James M (United States, Americas)Gilbertson Richard J (United States, Americas)
Source: Childs Nerv Syst 31, 1283–1289 (2015).
Date: May 1, 2015Please create a free account or log in to view this item
Registration is free, quick and easy. Simply register and complete your profile to get access. If you already have an account with the ISPN Library or ISPN Guide, login below.
Create an account
Login
Register
Log in using your ISPN Guide or ISPN Library credentials
Not yet registered? Join now



















